Nanobiotix (NBTX) Enterprise Value: 2019-2025

  • Nanobiotix's Enterprise Value rose 18.06% to $191.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$13.9 million, marking a year-over-year decrease of 47.30%. This contributed to the annual value of $108.1 million for FY2024, which is 38.24% down from last year.
  • Per Nanobiotix's latest filing, its Enterprise Value stood at $191.7 million for Q2 2025, which was up 77.34% from $108.1 million recorded in Q4 2024.
  • Over the past 5 years, Nanobiotix's Enterprise Value peaked at $351.2 million during Q2 2021, and registered a low of $65.1 million during Q2 2022.
  • For the 3-year period, Nanobiotix's Enterprise Value averaged around $158.2 million, with its median value being $162.4 million (2024).
  • Per our database at Business Quant, Nanobiotix's Enterprise Value slumped by 81.47% in 2022 and then spiked by 135.47% in 2023.
  • Quarterly analysis of 5 years shows Nanobiotix's Enterprise Value stood at $186.1 million in 2021, then slumped by 81.47% to $65.1 million in 2022, then surged by 135.47% to $175.5 million in 2023, then slumped by 38.40% to $108.1 million in 2024, then rose by 18.06% to $191.7 million in 2025.
  • Its Enterprise Value stands at $191.7 million for Q2 2025, versus $108.1 million for Q4 2024 and $162.4 million for Q2 2024.